Microbiology. Is the tide turning for new malaria medicines?
Wells
Timothy N C
TN
Medicines for Malaria Venture/MMV, 20, Route de Pré-Bois-Post Office Box 1826, Geneva, Switzerland. wellst@mmv.org
D000251:Adenosine Triphosphatases / Q000235:genetics; D000818:Animals; D000962:Antimalarials / Q000494:pharmacology* / Q000627:therapeutic use; D017277:Drug Approval; D055808:Drug Discovery; D004351:Drug Resistance; D004912:Erythrocytes / Q000469:parasitology; D017125:Genes, Protozoan; D006801:Humans; D007211:Indoles / Q000494:pharmacology* / Q000627:therapeutic use; D008288:Malaria / Q000188:drug therapy; D021261:Parasitic Sensitivity Tests; D010961:Plasmodium / Q000187:drug effects* / Q000235:genetics / Q000254:growth & development / Q000378:metabolism; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D015800:Protozoan Proteins / Q000096:biosynthesis; D013141:Spiro Compounds / Q000494:pharmacology* / Q000627:therapeutic use
D000962:Antimalarials; D007211:Indoles; C552304:NITD 609; D011500:Protein Synthesis Inhibitors; D015800:Protozoan Proteins; D013141:Spiro Compounds; D000251:Adenosine Triphosphatases